Abstract: An apparatus for performing blood therapy having a plurality of pumps for engaging blood and fluid tubing is characterized by a plurality of manually mounted and disengagable panels installed on the sides of the apparatus housing, the panels having pump engaging tubing mounted on the inside of the respective panels.

Abstract: An apparatus for performing blood therapy having a plurality of pumps for engaging blood and fluid tubing is characterized by a plurality of manually mounted and disengagable panels installed on the sides of the apparatus housing, the panels having pump engaging tubing mounted on the inside of the respective panels.

Abstract: An apparatus for performing blood therapy having a plurality of pumps for engaging blood and fluid tubing is characterized by a plurality of manually mounted and disengagable panels installed on the sides of the apparatus housing, the panels having pump engaging tubing mounted on the inside of the respective panels.

Abstract: In a blood therapy apparatus having a load cell sensor and a coupler for securing a load, a bag thereon is characterized by a free hanging link hanging from the coupler, and a bag hanger comprising an elongated rod having a plurality of bag engaging hooks and upwardly extending hook secured at the weight center of the rod and freely hanging from the links.

Abstract: A panel assembly for being manually mounted on a blood therapy apparatus is characterized by three panels, a center panel configured for manually securing a hemofilter cartridge and opposite side panels, hingedly connected to the center panel. The side panels have generally flat, planar interior surfaces defined by a rim extending around its perimeter. Tubing is secured along and adjacent to the interior panel surfaces, which are also provided with tubing supports having slanted tubing channels for supporting arched pump rotor engaging tubing sections and prevent tubing droop.

Abstract: An extracorporeal blood therapy control unit housing has a first and second manually mounted panels and spring loaded components configured for releasably engaging and tensioning the said panels against a side of said housing. The first and second panels have arch-shaped tubing segments mounted on the interior side of said respective panels. Each of the tubing segments are held in operational engagement with a different peristaltic pump rotor by the panel engaging and tensioning components.

Abstract: An apparatus for carrying out selected fluid management and/or renal replacement patient therapy is characterized by an interactive operator control system having operator inputs for selectively changing a panel kit, replacing a filter cartridge, and/or changing to a different patient therapy during a currently running patient therapy, and providing operator instructions for carrying out tasks for completing same. In one embodiment, the interactive operator control system is also characterized by automatically serially identifying different setup steps to be carried out during system setup, displaying the successive steps substantially throughout the system setup as well as displaying on the operator interface screen sequential tasks to be carried out for each of the different setup steps.

Abstract: An apparatus configured for carrying out CRRT on patients weighing up to about 20 kg incorporates a control unit having a blood pump and a plurality of fluid pumps mounted thereon, and a controller configured for operating the blood pump and fluid pumps, and an interactive operator control system including an operator interface screen operatively connected to the controller, the controller including software configured to operate the apparatus in response to operator input selections. The interactive operator control system includes operator inputs for setting patient weight, blood pump flow rate and fluid pump flow rates and the controller is configured to calculate and display maximum allowable fluid gain or loss based solely on patient weight settings between zero kg and about 20 kg and trigger warnings and alarms for selected or calculated levels of patient fluid gain or loss and stop operation of the pumps or termination of CRRT in response to patient fluid gain or loss in excess of the maximum.

Abstract: An apparatus for carrying out selected fluid management and/or renal replacement patient therapy is characterized by an interactive operator control system having operator inputs for selectively changing a panel kit, replacing a filter cartridge, and/or changing to a different patient therapy during a currently running patient therapy, and providing operator instructions for carrying out tasks for completing same. In one embodiment, the interactive operator control system is also characterized by automatically serially identifying different setup steps to be carried out during system setup, displaying the successive steps substantially throughout the system setup as well as displaying on the operator interface screen sequential tasks to be carried out for each of the different setup steps.

Abstract: A panel assembly for being manually mounted on a blood therapy apparatus is characterized by three panels, a center panel configured for manually securing a hemofilter cartridge and opposite side panels, hingedly connected to the center panel. The side panels have generally flat, planar interior surfaces defined by a rim extending around its perimeter. Tubing is secured along and adjacent to the interior panel surfaces, which are also provided with tubing supports having slanted tubing channels for supporting arched pump rotor engaging tubing sections and prevent tubing droop.

Abstract: In a blood therapy apparatus having a load cell sensor and a coupler for securing a load, a bag thereon is characterized by a free hanging link hanging from the coupler, and a bag hanger comprising an elongated rod having a plurality of bag engaging hooks and upwardly extending hook secured at the weight center of the rod and freely hanging from the links.

Abstract: An extracorporeal blood therapy control unit housing has a first and second manually mounted panels and spring loaded components configured for releasably engaging and tensioning the said panels against a side of said housing. The first and second panels have arch-shaped tubing segments mounted on the interior side of said respective panels. Each of the tubing segments are held in operational engagement with a different peristaltic pump rotor by the panel engaging and tensioning components.

Abstract: An apparatus for performing blood therapy having a plurality of pumps for engaging blood and fluid tubing is characterized by a plurality of manually mounted and disengagable panels installed on the sides of the apparatus housing, the panels having pump engaging tubing mounted on the inside of the respective panels.

Abstract: Apparatus for carrying out therapeutic apheresis includes a filter device for being implanted in a blood vessel for carrying out in-vivo plasma separation having one or more elongated hollow tubes and a plurality of elongated hollow microporous fibers capable of separating plasma from whole blood at pressure and blood flow within a patient's vein, a multiple lumen catheter secured to the proximal end of the filter device having one or more lumens in fluid communication with the interior of said one or more hollow tubes and a plasma return lumen, and therapeutic apheresis apparatus for removing and/or separating selected disease-related components from the separated plasma and means for directing plasma between said catheter and the selective component removal apparatus.

Abstract: Method for in-vivo plasmapheresis utilizing a plurality of elongated hollow microporous filter fibers periodically interrupt diffusion of blood plasma from a patient, and, for a selected time, directing backflush fluid into the fibers at a pressure and interval sufficient to cleanse the fiber pores, after which plasma diffusion is resumed. The backflush fluid, preferably a normal saline solution, may contain an anticoagulant such as heparin, citrate or NO donor in suitable concentration for systemic anti-coagulation or for treating the fiber for thromboresistance.

Abstract: Apparatus for carrying out therapeutic apheresis includes a filter device for being implanted in a blood vessel for carrying out in-vivo plasma separation having one or more elongated hollow tubes and a plurality of elongated hollow microporous fibers capable of separating plasma from whole blood at pressure and blood flow within a patient's vein, a multiple lumen catheter secured to the proximal end of the filter device having one or more lumens in fluid communication with the interior of said one or more hollow tubes and a plasma return lumen, and therapeutic apheresis apparatus for removing and/or separating selected disease-related components from the separated plasma and means for directing plasma between said catheter and the selective component removal apparatus.

Abstract: A method for carrying out therapeutic apheresis comprises separating plasma from whole blood in-vivo and removing selected disease-related components from the separated plasma. Apparatus for carrying out therapeutic apheresis includes a filter device for being implanted in a blood vessel for carrying out in-vivo plasma separation having one or more elongated hollow tubes and a plurality of elongated hollow microporous fibers capable of separating plasma from whole blood at pressure and blood flow within a patient's vein, a multiple lumen catheter secured to the proximal end of the filter device having one or more lumens in fluid communication with the interior of said one or more hollow tubes and a plasma return lumen, and therapeutic apheresis apparatus for removing and/or separating selected disease-related components from the separated plasma and means for directing plasma between said catheter and the selective component removal apparatus.

Abstract: A method for carrying out therapeutic apheresis comprises separating plasma from whole blood in-vivo and removing selected disease-related components from the separated plasma. Apparatus for carrying out therapeutic apheresis includes a filter device for being implanted in a blood vessel for carrying out in-vivo plasma separation having one or more elongated hollow tubes and a plurality of elongated hollow microporous fibers capable of separating plasma from whole blood at pressure and blood flow within a patient's vein, a multiple lumen catheter secured to the proximal end of the filter device having one or more lumens in fluid communication with the interior of said one or more hollow tubes and a plasma return lumen, and therapeutic apheresis apparatus for removing and/or separating selected disease-related components from the separated plasma and means for directing plasma between said catheter and the selective component removal apparatus.

Abstract: Apparatus and method for in-vivo plasmapheresis utilizing a plurality of elongated hollow microporous filter fibers periodically interrupt diffusion of blood plasma from a patient, and, for a selected time, backflush fluid into the fibers at a pressure and interval sufficient to cleanse the fiber pores, after which plasma diffusion is resumed. The backflush fluid, preferably a normal saline solution, may contain an anticoagulant such as heparin in suitable concentration for systemic anti-coagulation or for treating the fiber for thromboresistance.

Abstract: Apparatus and method for in-vivo plasmapheresis utilizing a plurality of elongated hollow microporous filter fibers periodically interrupt diffusion of blood plasma from a patient, and, for a selected time, backflush fluid into the fibers at a pressure and interval sufficient to cleanse the fiber pores, after which plasma diffusion is resumed.